Joaquin Duato - 14 Feb 2022 Form 4 Insider Report for JOHNSON & JOHNSON (JNJ)

Role: CEO, Director
Signature: Raavi K. Deol, as attorney-in-fact for Joaquin Duato
Issuer symbol: JNJ
Transactions as of: 14 Feb 2022
Net transactions value: -$397,811
Form type: 4
Filing time: 15 Feb 2022, 19:04:13 UTC
Previous filing: 19 Jan 2022
Next filing: 18 Jan 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	JNJ	Common Stock	Options Exercise	$0	+5,424	+2.4%	$0.000000	231,521	14 Feb 2022	Direct	F1
transaction	JNJ	Common Stock	Tax liability	$397,811	-2,356	-1%	$168.85	229,165	14 Feb 2022	Direct	F2
holding	JNJ	Common Stock						784	14 Feb 2022	By 401k	F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	JNJ	Restricted Share Units	Options Exercise	$0	-5,424	-100%	$0.000000^*	0	14 Feb 2022	Common Stock	5,424		Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019; converted into shares of Common Stock upon vesting.
F2	Shares withheld for payment of taxes upon vesting of Restricted Share Units.
F3	Includes shares accrued due to dividend reinvestment in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (1/31/2022).